Ipamorelin is a selective growth hormone secretagogue acting on the ghrelin receptor. Its distinguishing feature among peptides of this class is selectivity: unlike GHRP-6, it is not associated with a pronounced appetite increase, and unlike GHRP-2 it has little reported effect on cortisol or prolactin. The Genopharm vial is labelled “Growth & GH Pathway Research”.
This pack contains one vial holding 5 mg of Ipamorelin as a dry powder, requiring reconstitution before use.
Key Benefits
- Selective ghrelin-receptor agonist studied for growth hormone release
- Reported as having little effect on appetite, cortisol or prolactin, unlike older secretagogues
- Commonly studied in combination with a GHRH analogue such as CJC-1295
- Supplied as a 5 mg multi-dose vial of lyophilised powder
Instructions
- Reconstitution: mix with bacteriostatic water or sodium chloride solution, swirl gently (do not shake)
- Administration: subcutaneous injection, per the vial labelling
- Dosage and cycle length: follow the guidance supplied with your order
Side Effects & Warnings
- Not an approved medicine in the EU; sold for research purposes
- Prohibited in competitive sport under WADA rules
- Mild water retention, headache or flushing are reported with GH-axis peptides
- Should only be used after consulting a qualified healthcare professional
- Not evaluated for use by minors, or during pregnancy or breastfeeding
Storage
Store the unmixed vial refrigerated at 2-8 °C, and keep the reconstituted solution refrigerated as well, using it within the recommended timeframe after mixing. For subcutaneous use only.
Reviews
There are no reviews yet